Grant to Advance Clinical Utility of Biomarkers in Cancer Care in New York (USA)
GrantID: 69397
Grant Funding Amount Low: $250,000
Deadline: October 14, 2026
Grant Amount High: $250,000
Summary
This grant supports advancing the clinical utility of molecular, cellular, and imaging biomarkers, specifically focusing on cancer detection, diagnosis, prognosis, treatment response prediction, and monitoring. This Notice of Funding Opportunity (NOFO) aims to enhance cancer diagnostics and treatments by fostering the clinical adoption of validated, robust biomarker assays. Through this initiative, researchers can contribute to the development of precision tools that enable more accurate and effective cancer care, ultimately improving patient outcomes and advancing personalized oncology...
Eligible Regions
Interests
Eligible Requirements
Grant Detailed Description
View Full Grant Details
Additional Criteria of Eligibility
Additional Funding in Information
Estimated Size of Grant
Contact Info
Funding Source
Overview
This grant is meant to financially support organizations or entities that focus their efforts on, but not limited to: Black, Indigenous, People of Color, Business & Commerce, Health & Medical, Municipalities, Non-Profit Support Services, Science, Technology Research & Development in New York (USA).